|
|||||
|
|
Therapeutic inertia related to the injectable glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary care |
|
| Authors: | Lill-Brith von Arx PhD Jonathan Rachman MBChB Joanne Webb MBChB Caroline Casey PhD Amisha Patel PhD Christina Diomatari MSc Robert Wood BSc Iskandar Idris Dm |
| Affiliation: | 1. Eli Lilly and Company, Herlev, Denmark;2. Eli Lilly and Company, Basingstoke, UK;3. Adelphi Real World, Bollington, UK;4. University of Nottingham, Nottingham, UK |
| Abstract: | |
| Keywords: | dulaglutide GLP-1RA observational study primary care subcutaneous semaglutide therapeutic inertia type 2 diabetes |